- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin in cancer treatment
Authors
Keywords
-
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 206, Issue -, Pages 115323
Publisher
Elsevier BV
Online
2022-11-09
DOI
10.1016/j.bcp.2022.115323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin
- (2021) Mary Elizabeth Money et al. Frontiers in Oncology
- DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
- (2021) Jing Du et al. Cell Death & Disease
- Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
- (2021) Chaoyun Pan et al. Nature Communications
- RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction
- (2021) Mengxin Li et al. BIOCHEMICAL PHARMACOLOGY
- The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma
- (2021) Anthony D. Nehlsen et al. Clinical Lymphoma Myeloma & Leukemia
- Systemic therapies for intrahepatic cholangiocarcinoma
- (2020) Robin Kate Kelley et al. JOURNAL OF HEPATOLOGY
- Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
- (2020) Ufuk Degirmenci et al. Cells
- Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study
- (2020) Marie José Kersten et al. HAEMATOLOGICA
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities
- (2020) Gerda de Vries et al. CANCER TREATMENT REVIEWS
- Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells
- (2020) Yunxia Li et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Mechanisms of Cancer Resistance to Immunotherapy
- (2020) Rilan Bai et al. Frontiers in Oncology
- In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
- (2020) Maryam Sadat Ashrafzadeh et al. International Journal of Nanomedicine
- Immunotherapy for osteosarcoma
- (2020) Kenichiro Yahiro et al. Human Vaccines & Immunotherapeutics
- Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
- (2019) Neife Aparecida Guinaim dos Santos et al. FOOD AND CHEMICAL TOXICOLOGY
- MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
- (2018) Lingtao Jin et al. CANCER CELL
- Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity
- (2018) Tom T. G. Nieskens et al. DRUG METABOLISM AND DISPOSITION
- Aldehyde-Induced DNA and Protein Adducts as Biomarker Tools for Alcohol Use Disorder
- (2018) Helen M. Heymann et al. TRENDS IN MOLECULAR MEDICINE
- Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial
- (2018) John J. Coen et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of ω-3 fatty acids and cisplatin as a potential alternative strategy for personalized therapy of metastatic melanoma
- (2018) Renata Ottes Vasconcelos et al. MELANOMA RESEARCH
- Modulation of cisplatin cytotoxic activity against leiomyosarcoma cells by epigallocatechin-3-gallate
- (2017) Irida Th. Dhima et al. NATURAL PRODUCT RESEARCH
- A Systematic Review of Strategies to Prevent Cisplatin‐Induced Nephrotoxicity
- (2017) Daniel J. Crona et al. ONCOLOGIST
- Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria
- (2016) Sofia Waissbluth et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future
- (2015) A. Avan et al. ONCOLOGIST
- Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol
- (2014) Katherine P. Morgan et al. ANNALS OF PHARMACOTHERAPY
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
- (2014) A. R. de Biasi et al. CLINICAL CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin
- (2014) Nasma D. Eljack et al. Metallomics
- Lhermitte's Phenomenon and Platinum, Beware of Latency
- (2014) Aine O'Reilly et al. Oncology Research and Treatment
- Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
- (2014) Aparna Areti et al. Redox Biology
- Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
- (2013) Francesco Tadini-Buoninsegni et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
- (2013) F Meng et al. BRITISH JOURNAL OF CANCER
- Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
- (2012) Connie Jackaman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
- (2012) C.-L. Chang et al. CANCER RESEARCH
- MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells
- (2012) Jean-Philippe Guégan et al. CARCINOGENESIS
- Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells
- (2012) Yun Chen et al. JOURNAL OF PEDIATRIC SURGERY
- Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
- (2011) A. Shrivastava et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
- (2010) et al. CLINICAL CANCER RESEARCH
- Rituximab, Dexamethasone, Cytarabine, and Oxaliplatin (R-DHAX) Is an Effective and Safe Salvage Regimen in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
- (2010) Julie Lignon et al. Clinical Lymphoma Myeloma & Leukemia
- The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
- (2010) Anamaria Brozovic et al. CRITICAL REVIEWS IN TOXICOLOGY
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- (2010) Rupal Ramakrishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- Persistent neuropathy after treatment with cisplatin and oxaliplatin
- (2009) Elke E. M. Brouwers et al. ACTA ONCOLOGICA
- Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma
- (2009) Q.-Q. Li et al. DISEASES OF THE ESOPHAGUS
- Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals
- (2009) Sigal Shachar et al. EMBO JOURNAL
- Chemotherapy with Cisplatin and Vincristine for Optic Pathway/Hypothalamic Astrocytoma in Young Children
- (2009) Y. Sawamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy
- (2009) Huibo Wang et al. NEURO-ONCOLOGY
- Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children
- (2008) O. Bede et al. INFLAMMATION RESEARCH
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal
- (2008) Jaffer A. Ajani JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started